Michael Breen has been appointed as the CEO of GT Biopharma, Inc. as of August 14, 2026.
1 report, 1 independent
Updated Aug 14
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Michael Breen has been appointed as the CEO of GT Biopharma, Inc. as of August 14, 2026.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Michael Breen
British writer and journalist
Nothing else this week.